126 related articles for article (PubMed ID: 24670448)
21. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J
Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020
[TBL] [Abstract][Full Text] [Related]
22. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
[TBL] [Abstract][Full Text] [Related]
23. Detection of miR-106a in gastric carcinoma and its clinical significance.
Xiao B; Guo J; Miao Y; Jiang Z; Huan R; Zhang Y; Li D; Zhong J
Clin Chim Acta; 2009 Feb; 400(1-2):97-102. PubMed ID: 18996365
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implications of serum microRNA-21 in colorectal cancer.
Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
[TBL] [Abstract][Full Text] [Related]
25. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer.
Cui L; Zhang X; Ye G; Zheng T; Song H; Deng H; Xiao B; Xia T; Yu X; Le Y; Guo J
Cancer; 2013 May; 119(9):1618-26. PubMed ID: 23335180
[TBL] [Abstract][Full Text] [Related]
26. Serum
Wang N; Zeng L; Li Z; Zhen Y; Chen H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
[TBL] [Abstract][Full Text] [Related]
28. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
[TBL] [Abstract][Full Text] [Related]
29. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.
Giráldez MD; Lozano JJ; Ramírez G; Hijona E; Bujanda L; Castells A; Gironella M
Clin Gastroenterol Hepatol; 2013 Jun; 11(6):681-8.e3. PubMed ID: 23267864
[TBL] [Abstract][Full Text] [Related]
30. miR-106a overexpression and pRB downregulation in sporadic colorectal cancer.
Catela Ivkovic T; Aralica G; Cacev T; Loncar B; Kapitanovic S
Exp Mol Pathol; 2013 Feb; 94(1):148-54. PubMed ID: 23178825
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer.
Li JM; Zhao RH; Li ST; Xie CX; Jiang HH; Ding WJ; Du P; Chen W; Yang M; Cui L
Saudi Med J; 2012 Jan; 33(1):24-9. PubMed ID: 22273643
[TBL] [Abstract][Full Text] [Related]
32. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770
[No Abstract] [Full Text] [Related]
33. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
34. A Clinical Evaluation of Circulating MiR-106a and Raf-1 as Breast Cancer Diagnostic and Prognostic Markers.
Ahmed Mohmmed E; Shousha WG; El-Saiid AS; Ramadan SS
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3513-3520. PubMed ID: 34837907
[TBL] [Abstract][Full Text] [Related]
35. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer.
Nonaka R; Nishimura J; Kagawa Y; Osawa H; Hasegawa J; Murata K; Okamura S; Ota H; Uemura M; Hata T; Takemasa I; Mizushima T; Okuzaki D; Yamamoto H; Doki Y; Mori M
Oncol Rep; 2014 Dec; 32(6):2354-8. PubMed ID: 25269744
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological significance of microRNA-21 and miR-125 expression in colorectal cancer].
Zhang Y; Zhou ZG; Wang L; Zhang P; Wang MJ; Cui CF; Guan JT; Chen KL; Zhan L
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):623-6. PubMed ID: 19921579
[TBL] [Abstract][Full Text] [Related]
37. Circulating miR-34a levels are reduced in colorectal cancer.
Nugent M; Miller N; Kerin MJ
J Surg Oncol; 2012 Dec; 106(8):947-52. PubMed ID: 22648208
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
[TBL] [Abstract][Full Text] [Related]
39. Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.
Liu GH; Zhou ZG; Chen R; Wang MJ; Zhou B; Li Y; Sun XF
Tumour Biol; 2013 Aug; 34(4):2175-81. PubMed ID: 23625654
[TBL] [Abstract][Full Text] [Related]
40. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
